These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20227452)

  • 1. A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
    van Nieuwenhuijzen PS; Kashem MA; Matsumoto I; Hunt GE; McGregor IS
    Neurochem Int; 2010 Jul; 56(8):871-7. PubMed ID: 20227452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly gamma-hydroxybutyrate exposure sensitizes locomotor hyperactivity to low-dose 3,4-methylenedioxymethamphetamine in rats.
    van Nieuwenhuijzen PS; Li KM; Hunt GE; McGregor IS
    Neuropsychobiology; 2009; 60(3-4):195-203. PubMed ID: 19893336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
    van Nieuwenhuijzen PS; McGregor IS
    Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
    van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: surface expression of CaMKII and NMDA receptor subunits.
    Moyano S; Del Río J; Frechilla D
    Pharmacol Biochem Behav; 2005 Sep; 82(1):190-9. PubMed ID: 16154187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex.
    Kemmel V; Klein C; Dembélé D; Jost B; Taleb O; Aunis D; Mensah-Nyagan AG; Maitre M
    Physiol Genomics; 2010 Apr; 41(2):146-60. PubMed ID: 20103696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
    Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential protein expression profiles in the hippocampus of human alcoholics.
    Matsuda-Matsumoto H; Iwazaki T; Kashem MA; Harper C; Matsumoto I
    Neurochem Int; 2007; 51(6-7):370-6. PubMed ID: 17513015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
    J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period.
    Piper BJ; Meyer JS
    Pharmacol Biochem Behav; 2004 Dec; 79(4):723-31. PubMed ID: 15582680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine.
    Eun JW; Kwack SJ; Noh JH; Jung KH; Kim JK; Bae HJ; Xie H; Ryu JC; Ahn YM; Min JH; Park WS; Lee JY; Rhee GS; Nam SW
    Toxicol Appl Pharmacol; 2009 May; 237(1):91-101. PubMed ID: 19285098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY
    Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats.
    Clemens KJ; Cornish JL; Hunt GE; McGregor IS
    Drug Alcohol Depend; 2007 Jan; 86(2-3):183-90. PubMed ID: 16884865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo analysis of serotonin clearance in rat hippocampus reveals that repeated administration of p-methoxyamphetamine (PMA), but not 3,4-methylenedioxymethamphetamine (MDMA), leads to long-lasting deficits in serotonin transporter function.
    Callaghan PD; Owens WA; Javors MA; Sanchez TA; Jones DJ; Irvine RJ; Daws LC
    J Neurochem; 2007 Feb; 100(3):617-27. PubMed ID: 17181558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
    Sumnall HR; O'Shea E; Marsden CA; Cole JC
    Pharmacol Biochem Behav; 2004 Apr; 77(4):805-14. PubMed ID: 15099927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.